|
C18ORF8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.88982999999032E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.157800E-04 |
| Normal-vs-Stage2 |
3.09679999999091E-06 |
| Normal-vs-Stage3 |
2.26729999999176E-05 |
| Normal-vs-Stage4 |
1.966330E-04 |
| Stage1-vs-Stage2 |
2.008200E-02 |
| Stage1-vs-Stage3 |
8.608400E-02 |
| Stage1-vs-Stage4 |
1.245240E-01 |
| Stage2-vs-Stage3 |
3.331000E-01 |
| Stage2-vs-Stage4 |
5.214200E-01 |
| Stage3-vs-Stage4 |
8.242600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.71990000000078E-05 |
| Normal-vs-AfricanAmerican |
7.360100E-02 |
| Normal-vs-Asian |
1.038340E-02 |
| Caucasian-vs-AfricanAmerican |
3.747600E-01 |
| Caucasian-vs-Asian |
5.100600E-01 |
| AfricanAmerican-vs-Asian |
7.240000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.51337999999557E-05 |
| Normal-vs-Female |
8.17499999999916E-05 |
| Male-vs-Female |
1.992830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.155900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.65019999945437E-07 |
| Normal-vs-Age(61-80Yrs) |
4.25959999994507E-06 |
| Normal-vs-Age(81-100Yrs) |
1.849240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.500900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.979800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.619800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.525600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.175800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.653800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.232200E-01 |
| Classical-VS-Follicular |
2.267600E-02 |
| Classical-VS-Other |
4.425800E-01 |
| Classical-VS-Normal |
1.355400E-04 |
| Tall-VS-Follicular |
4.902200E-01 |
| Tall-VS-Other |
7.176800E-01 |
| Tall-VS-Normal |
4.142800E-03 |
| Follicular-VS-Other |
9.875800E-01 |
| Follicular-VS-Normal |
1.59314999998994E-05 |
| Other-VS-Normal |
2.772000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83740000003763E-06 |
| Normal-vs-N1 |
2.229800E-04 |
| N0-vs-N1 |
7.939000E-01 |
|
|
